Results 181 to 190 of about 790,517 (360)
Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1‐phosphate [PDF]
Ken Motohashi +4 more
openalex +1 more source
Targeting macrophages prevents alloantibody-mediated platelet clearance in a murine model of transfusion refractoriness. [PDF]
Rojas-Jiménez G +4 more
europepmc +1 more source
Transition metal oxy/carbo‐nitrides show great promise as catalysts for sustainable processes. A Mn‐Mo mixed‐metal oxynitride attains remarkable performance for the direct synthesis of acetonitrile, an important commodity chemical, via sequential C─N and C─C coupling from syngas (C1) and ammonia (N1) feedstocks.
M. Elena Martínez‐Monje +7 more
wiley +1 more source
Functional toll-like receptor 4 links endotoxin sensing to platelet priming in feline platelets. [PDF]
Li RHL +5 more
europepmc +1 more source
Mourad, Salma de Carvalho +2 more
openaire +4 more sources
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source
Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. [PDF]
E Minar +7 more
openalex +1 more source
The evolving landscape of platelet therapy: risks, innovations, and clinical judgment. [PDF]
Mushtaq A +5 more
europepmc +1 more source
Kelvin Probe Force Microscopy in Bionanotechnology: Current Advances and Future Perspectives
Kelvin probe force microscopy (KPFM) enables the nanoscale mapping of electrostatic surface potentials. While widely applied in materials science, its use in biological systems remains emerging. This review presents recent advances in KPFM applied to biological samples and provides a critical perspective on current limitations and future directions for
Ehsan Rahimi +4 more
wiley +1 more source

